Oxford Finance LLC β Full Portfolio
9 tracked investments Β· listed companies and verified rows first
Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.
BiotechEmeryville, US
Warner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)Peter Maag(Executive Officer, Director)in
Co-investorsBain Capital Life SciencesVida VenturesWestlake Village BioPartnersGilead SciencesKleiner PerkinsRTW Investments L.P.+1 more
Amino Labs produces hands-on biotechnology experiment kits designed to teach genetic engineering and bacterial transformation to beginners in educational and hobbyist settings.
BiotechEdTechSouthern Alberta, CA
Julie Legault(CEO)inJustin Pahara(Biotechnology Expert)
Co-investorsSOSVThe E14 FundAccelAspect VenturesCRV (Charles River Ventures)Highland Capital Partners+1 more
Narvii.com is an independent information website that publishes articles about digital platforms, online communities, and popular apps.
Creator EconomyMedia & EntertainmentSocial
Alexander Smith(Editor-in-Chief)
Co-investorsBantam GroupHighland Capital PartnersTRANSFORMATION CAPITAL
Fynd provides a commerce platform with AI agents for sales and support, letting brands build websites, sell on marketplaces (Amazon, Myntra, Noon, Trendyol), run wholesale operations, modernise retail stores, and manage orders, payments, and logistics.
AI & Machine LearningE-commerceRetail TechSaaSSeattle, US
Farooq Adam(Founder)inNicolas Nezhat(President)
Co-investorsRocketship.vcVelocityTrinity CapitalVenture Catalysts
Inhibrx develops protein therapeutics, using target biology and protein engineering to create therapeutic candidates in clinical trials for conditions including sarcoma and head and neck cancer.
BiotechLa Jolla, US
Mark Lappe(Executive Officer, Director)inBrendan Eckelman(Director)inDoug Forsyth(Director)Jon Faiz Kayyem(Director)Margery Fischbein(Director)
BoardJudith Li(Director)
Co-investorsLAVLilly Asia VenturesRA Capital
BiotechBridgewater, US
Navneet Puri(Executive Officer)
Co-investorsH.I.G. CapitalH.I.G. HealthBridge Partners
A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Co-investorsCapital Midwest FundFrazier Life SciencesLongitude CapitalRA CapitalVivo Capital
Tarsa Therapeutics developed TBRIA, an oral formulation of calcitonin for treating postmenopausal osteoporosis in women more than five years post menopause when other treatments are unsuitable.
BiotechPhiladelphia, US
David Brand(Executive Officer, Director)inGregory Lumpkin(Executive Officer)
BoardRichard Kollender(Director)Martin Edwards(Director)Eric Bednarski(Director)Derek Ferguson(Director)
Co-investorsForesite CapitalMVM Life Science PartnersQuaker BioVentures
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.